I guess in hindsight (which is always 20/20...) the quick trade would have been to: * buy units in the fund when it was announced it was going to list at NAV * sell off on market after the listing for a premium to NAV
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025